MPAC conclusions and recommendations: September 2016

MPAC conclusions and recommendations: September 2016 

On 14–16 September 2016, the WHO Malaria Policy Advisory Committee (MPAC) convened to review updates and progress, and provide guidance with respect to specific thematic areas of work carried out by the Global Malaria Programme.

The meeting focused on: (1) an update on the RTS,S vaccine pilot implementation programme; (2) an update on the malaria elimination in the Greater Mekong subregion; (3) a review of Malaria elimination: an operational manual; (4) the results from a multi-country evaluation of the impact of insecticide resistance on malaria vector control; (5) an update on the Strategic Advisory Group on malaria eradication; (6) an update on the development of guidelines for malaria vector control; (7) the development of the Global Vector Control Response; (8) a proposed evidence review group to consider the cardiotoxicity of antimalarial medicines; (9) a report on the WHO technical consultation on detection and surveillance of HRP2/HRP3 deletions; (10) recommendations for the surveillance, monitoring and evaluation taskforce; (11) a proposed evidence review group to review Plasmodium knowlesi; (12) the proposed target product profile for ivermectin; and (13) proposed plans for the World Malaria Report.